SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: g.w. barnard who wrote (16810)12/10/1998 8:55:00 AM
From: DaiS  Read Replies (1) | Respond to of 23519
 
Smith, W.L., Melman, C., Sato, Y., Zhao, W., Day, N.S., Valcic, M.,
Sclafani, T., Bakal, R., and Christ, G.J.: Gene therapy with hSlo naked DNA preserves erectile capacity following 12-16 months of experimental diabetes in rats. Abstract, Accepted for presentation at the Keystone Symposium in Molecular and cellular biology of gene therapy. Jan., 1999.

(Vlad, I had the title at work, sorry don't have abstract itself yet)



To: g.w. barnard who wrote (16810)12/10/1998 9:17:00 AM
From: KHS  Read Replies (1) | Respond to of 23519
 
Will we have some pressure from tax selling starting today? Many bought 12/10/97 and now can sell those shares as long term loss offsetting long term gains.

I'd participate in the letter but apathy has set in.